3/31
08:55 am
erna
Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026
Medium
Report
Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026
2/20
09:46 am
erna
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series [Yahoo! Finance]
High
Report
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series [Yahoo! Finance]
2/20
09:05 am
erna
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
High
Report
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
2/6
09:25 am
erna
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering
High
Report
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering
2/3
08:45 am
erna
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA
High
Report
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA
1/27
08:45 am
erna
Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program
Medium
Report
Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program